Introduction
Severe chest wall deformities, such as kyphoscoliosis and tuberculosis sequellae may lead to secondary chronic restrictive respiratory failure (CRF). In these patients, long-term nocturnal non-invasive mechanical ventilation (NIV) is now recognized as first line therapy. NIV has been reported to improve daytime arterial blood gases, survival and to reduce rates of hospitalizations. [1] [2] [3] Chest wall diseases represent 30% of home-treated NIV patients in Europe i.e. approximately 8000 patients. 4 As these patients' exhibit increased survival, it becomes necessary to focus on their persistent disability and alterations in quality of life. Exercise intolerance and dyspnea are among the major complaints preventing patients with severe restrictive chest wall disease from participating in activities of daily life. Pulmonary rehabilitation may be of value for these patients in whom respiratory symptoms and diminished healthrelated quality of life may be observed. To date, there is no formal evidence-based guidelines for exercise activities in restrictive lung disease, and 'expert opinion based on pathophysiology and clinical experience is recommended'.
5
Ambulatory oxygen therapy improves dyspnea but not a 6 min walking distance, thus suggesting a limited interest for such a treatment during rehabilitation in restrictive patients. 6 Using NIV during daily exercise could be a part of the rehabilitation program but few data are available on this strategy.
The use of NIV during exercise has been studied in chronic obstructive pulmonary disease patients (COPD) since the early 1990s. [7] [8] [9] [10] [11] [12] [13] [14] [15] For such patients, NIV during exercise may improve exercise endurance and reduce dyspnea. 15 To our knowledge, only two studies have assessed the role of NIV during exercise in CRF patients. 16, 17 One study reported improvement in endurance time and reduction in breathlessness 17 in a small population (n ¼ 7 patients) whereas the other study 16 did not find any improvement. Although the latter study evaluated the response, during exercise, NIV compared with spontaneous breathing also included a small number of patients (n ¼ 8). Moreover, the mean preset inspiratory positive airway pressure (IPAP) (13.7 cm H 2 O) led to a moderate increase in minute ventilation during exercise (18%) which may have modified the benefits of NIV. Since exercise limitation in chest wall restrictive patients may be related to the severity of the restrictive disorder, it is important to study the efficacy of NIV in relation to (i) the severity of the underlying disease and (ii) the ability of NIV to maximize the increase in minute ventilation during exercise. This prospective randomized trial set out to study the acute effects of the application of support ventilation as an aid to increase exercise endurance in a group of CRF patients with a broad range of functional impairment.
Materials and methods

Patients
Patients were eligible for the study if they presented the following criteria: 
Study design
Patients were seen on two different occasions 1 week apart. On the first visit, patients underwent pulmonary function tests, a maximal incremental exercise test (MWLE) and a 6 min walking test (6MWT). On a second visit, patients were initially adapted to the use of NIV during exercise, and then were allowed to rest for 30 min. Patients subsequently performed two constant workload exercise tests (CWLE) at 75% of peak workload, with and without NIV in a random order. Subjects were allowed to rest during 30-45 min between the two tests.
Respiratory function and maximal workload exercise testing
Spirometry and thoracic gas volumes were measured using Pitot pneumotachograph and pressure plethysmograph (MEDICAL GRAPHICS Corporation, St. Paul, MN, USA). sniff nasal inspiratory pressure (SNIP) was determined at functional residual capacity using a pressure sensor (Validyne7200 cm H 2 O) connected to a digital recorder (Direc NEP System 200, Raytech Instruments Inc.; Vancouver; Canada) according to ATS/ERS statement. A 6 MWT was performed in ambient air along a straight 30 m long corridor. All these tests were performed according to the ATS guidelines statement. [18] [19] [20] Arterial blood gases (Radiometer, Cophenhagen) were performed at rest, at least 4 h after the end of nocturnal NIV treatment.
Maximal workload exercise test was performed on an electromechanically braked cycle Ergometer (900PC, ERGO-LINE, Germany). Work rate was increased every minute by 10% of the expected maximal workload until exhaustion. Minute ventilation (VE), oxygen uptake (VO 2 ), carbon dioxide exhalation (VCO 2 ), respiratory rate (RR), tidal volume (Vt) were measured using breath-by-breath automated exercise metabolic system (Sensormedics, Vmax 229; Yorba Linda, CA, USA). Peak power (W peak ) was determined as the highest work rate that the patient completed during 1 full minute.
Constant workload exercise testing (CWLE)
The two endurance tests were performed at 75% W peak on the same cycle-ergometer, with NIV or in spontaneous breathing (SB) in random order. Expired gases were collected in a mixing chamber for analysis of ventilatory
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and metabolic variables. VO 2 , VCO 2 , RR, Vt were averaged over 20 s time intervals. For the test in spontaneous breathing, the patient was connected via a mouth-piece to a two-way non-re-breathing valve (Model 2700, Hans Rudolph Inc., Kansas City, MO USA); the exhalation port was connected to the mixing chamber (see Figure 1b) . For the test with NIV, the exhalation valve of the ventilator was connected to the mixing chamber with a 30 mm diameter tubing (see Figure 1a) .
The patient warmed up at the lowest available work rate (20 W). The workload was then abruptly increased until the predetermined workload and continued until exhaustion. At the end of each minute, the patient indicated his level of dyspnea. The test was over when the patient could not maintain exercise because of dyspnea, fatigue or could not maintain 55 cycles/min.
All the tests were performed at the beginning of the afternoon.
Both during MWLE and CWLE, 12-lead electrocardiogram was monitored. SpO 2 was also continuously monitored. There was no oxygen supplementation even in case of desaturation. End-exercise arterial blood gases were sampled by direct arterial sampling.
Non-invasive positive pressure ventilation (NIV) (Figure 1a-c)
The ventilatory mode used for exercise was pressure support ventilation (PSV) in all patients. To avoid bias related to the choice of device, a single ventilator was used for all the patients (SMARTAIR +, AIROX, Pau, France). Settings during exercise were specifically tailored for appropriate ventilation during exercise and were systematically different from the nigh time settings. The patient chose the best-tolerated interface (nasal mask, naso-buccal mask, mouth-piece). IPAP was increased until the patient had a comfortable respiratory sensation ('enough air' at each insufflation). Flow trigger was set at the most sensitive value that prevented involuntary triggering during expiration. Expiratory trigger was set at À50% of maximal inspiratory flow. In order to avoid underestimation of VO 2 due to continuous 
Responders versus non-responders to acute NIV during exercise
We considered as 'responders to NIV', patients who increased CWLE time under NIV by more than 50% compared with spontaneous breathing. The threshold of 50% was chosen because it corresponds to approximately two times the coefficient of variance of test-retest CWLE time in COPD patients at the same exercise load. 21 
Statistical analysis
Results are expressed as mean7SD. NCSS 97 (Kaysville, Utah, USA) software was used for the statistical analysis.
Correlations were analyzed using non-parametric correlation Spearman test. Comparison between CWLE, under either NIV or spontaneous breathing was done with nonparametric paired test (Wilcoxon test).
Comparison between responders and non-responders to NIV were made using a non-parametric unpaired test (Mann-Withney test). For the two endurance tests (with NIV and in SB), ventilatory, metabolic and cardiac variables were compared at iso-time as defined by the longest duration achieved under either condition.
For all tests, a significance level of po0.05 was used.
Results
Patients (Table 1) Eighteen CRF patients [Total lung capacity (TLC) ¼ 59716% of predicted value] with a mean age of 63711 years were included in the study. All had significant reduction in lung volumes (mean FVC of 4477% of predicted value) and none had significant bronchial obstruction (FEV 1 /FVC ratio of 79710%). Nocturnal NIV had been initiated for 776 years on the basis of chronic hypoventilation (mean PaCO 2 at initiation of NIV: 52712 mmHg). All patients used their NIV at nighttime, but none was dependant upon respiratory assistance during the daytime. At the time of inclusion, mean PaCO 2 had improved with the regular use of nocturnal NIV (4375 mmHg). However, all patients complained of dyspnea during activities of daily life. 6MWT distance was reduced (3927131 m i.e. 80724% of predicted value) with a mean value of dyspnea on a Borg scale of 472 at the end of the test. The severity of impairment during exercise was also demonstrated by the mean VO 2peak ¼ 1274 ml/min/kg obtained during MWLE.
Effects of NIV during constant workload exercise in the whole group (n ¼ 18) (Table 2) The mean NIV pressure support adjusted for exercise was 1972 cm H 2 O. One patient chose to perform the test with a mouthpiece, nine with a nasal mask and eight with a nasobuccal mask. We did not find that the type of interface had a significant impact on the results (w 2 ¼ NS). CWLE time increased by 71% with NIV (p ¼ 0.01). Iso-time exercises VO 2 and VCO 2 were not significantly different using NIV or during SB. With NIV compared to SB, minute ventilation (VE) increased by 1677 l/min (po0.001) both by increasing tidal volume (Vt) by 0.670.2 litter (po0.001) and reducing respiratory rate (RR) by 475/min (po0.01). Mean SpO 2 increased by 476% (po0.01) with NIV. Mean heart rate (HR) was also significantly reduced with NIV at iso-time (p ¼ 0.04).
Several factors were associated with the increase in endurance time obtained with NIV. The increase in CWLE time during NIV significantly correlated with the reduction in exercise oxygen desaturation (r ¼ 0.67, p ¼ 0.006) (Figure 2a) . Moreover, the increase in CWLE time was related to the reduction in heart rate with NIV (r ¼ À0.53, p ¼ 0.03) (Figure 2c) . Finally, CWLE time correlated with the reduction in dyspnea at iso-time (r ¼ À0.60, p ¼ 0.02) (Figure 2b ).
Comparison between responders and nonresponders to NIV only 64730% in non-responders (p ¼ 0.03) ( Table 2) . Respiratory rate significantly decreased with NIV in the responders group only (p ¼ 0.01) ( Table 2) . Overall, responders tended to increase VE to a greater extent (70724% versus 52720% in responders and nonresponders, respectively (p ¼ 0.17)) ( Table 2) . Again, the mean HR during exercise tended to be reduced by NIV (p ¼ 0.1) whilst SpO 2 was significantly increased (p ¼ 0.008) ( Table 2) . As a consequence, dyspnea score at iso-time exercise was relieved with NIV (p ¼ 0.03) in the responder group only (Table 2) At the end of MWLE, both VE (p ¼ 0.04) and peak Vt (expressed in absolute value p ¼ 0.003), were significantly lower in responders (Table 3 ). In addition, functional dead space ratio (V D /V T ratio) was higher in responders (p ¼ 0.04). Finally, oxygen pulse at peak exercise was lower in responders (p ¼ 0.03).
Discussion
In patients with restrictive chronic respiratory failure, acute NIV during exercise allowed to extend constant workload exercise time by 71% as a mean value. The degree of improvement in CWLE time was significantly related to the reduction of oxygen desaturation, and the decrease in dyspnea and heart rate. Responders to NIV during exercise had lower TLC and FVC. At the end of MWLE in spontaneous breathing, tidal volume was lower in responders with a higher dead space on tidal volume ratio and a lower oxygen pulse. Responders to NIV were thus more severe in terms of ventilatory failure but also demonstrated more cardiac limitation as suggested by lower oxygen pulse.
NIV efficacy during constant workload exercise: comparison with previous studies
Only two studies have assessed the impact of acute NIV during effort in patients with CRF. 16, 17 Tsuboi et al. 17 studied seven restrictive patients (tuberculosis sequellae) and demonstrated that NIV significantly prolonged exercise endurance time. During exercise, NIV effectively decreased their breathlessness and significantly improved arterial blood gases measurements. This is in accordance with our results, even though in Tsuboi's study, the experimental setup was different including the use of volumetric ventilators and performing exercise in the supine position. In contrast with Tsuboi et al. and the current study, Highcock et al. 16 in a randomized controlled trial including eight restrictive patients showed a decrease in treadmill walk distance in patients when using PSV compared to an unencumbered test. Minute ventilation at breakpoint of exercise was only slightly increased (+17%) with NIV and oxygen saturation was not improved in this latter study. Given that expiratory pressure was set at 4 cm H 2 O means that mean pressure support was about 10 cm H 2 O whereas this pressure was about 19 cm H 2 O in the present study thus leading to a 60% increase in minute ventilation. As a consequence, in our patients, VE was increased by a mean of 16 l/min and mean oxygen saturation was improved by 4% on average. In summary, when compared to previous studies, the strengths of our study are as follows: (i) A randomized controlled trial design, (ii) a twofold increase in enrolled patients compared to previous studies, (iii) ventilator settings permitted a clinically significant increase in exercise ventilation when using NIV. The current study also exhibited some limitations. Even if our study is the largest one in the field, the number of included patients was relatively small and results need to be replicated in further large-scale studies. As patients had experienced NIV for a mean of 776 years, it was impossible to use Sham ventilation. A placebo effect could be part of the explanation for increase in exercise duration but could not account for reduction of oxygen desaturation and other physiological changes associated with NIV.
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Ventilatory and cardiovascular changes associated with increased endurance with NIV
The mean range for improvement in exercise duration using PSV was 71% in this study. This is more than 40-50% of the improvement previously demonstrated in COPD patients. 7, 14, 15 In restrictive patients, Naji et al. 22 showed an increase in exercise endurance (treadmill) of a mean of 8.7 min, which was associated with a significant improvement in quality of life. One may speculate that the 71% improvement that we achieved with NIV is at least as significant. The wide range of change in exercise duration when using NIV in the present study (i.e. from À2.6 to +27.5 min) as in others 14, 17, 23 illustrates that some patients benefit greatly from ventilatory support, although others do not or are even slightly impaired. NIV responders had both lower TLC and lower FVC which suggests that the most severe patients are those most likely to benefit. Secondly, Variation between heart rate with spontaneous breathing and heart rate with NIV at iso-time.
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during the MWLE in spontaneous breathing, responders had lower minute ventilation with lower tidal volume. As a consequence, reduced alveolar ventilation, higher V D /V T ratio and greater oxygen desaturation were observed at the end of exercise. Thus, one can understand that in responders the two-fold increase in Vt and 70% increase in VE provided by NIV have improved gas exchange and subsequent exercise ability. Surprisingly, VE was also significantly improved with NIV in non-responders (+52%) without benefit in terms of exercise tolerance. Ventilatory mechanical limitation was presumably not the main mechanism limiting exercise in these patients, and peripheral muscle fatigue may have a potential role. Even without NIV, these patients were able to perform CWLE for a longer duration (7.175.8 min versus 4.072.5, p ¼ 0.05) with limited oxygen desaturation. In such less severe patients, NIV does not seem to provide any additional effect. Another important difference between responders and non-responders could have been the ability to adjust cardiac output during exercise. Responders had lower oxygen pulse at the end of the MWLE suggesting limited ability to increase cardiac ejection during heavy exercise. Previous studies ARTICLE IN PRESS have demonstrated that cardiac output might be involved in exercise limitation in patients with thoracic or pulmonary restriction (see below).
24,25
Mechanisms explaining improvement in exercise ability using NIV A large increase in VE (61723%) and also Vt were obtained for the whole group when using NIV during exercise. The significant correlations between improvement in CWLE duration and SpO 2 improvement and dyspnea relief using NIV during exercise suggest that improving alveolar ventilation and gas exchange and/or minimizing symptoms by using NIV are the main factors explaining the increase in exercise duration. The present study is the first to demonstrate that an increase in minute ventilation sufficient to improve alveolar ventilation during exercise and presumably to avoid oxygen desaturation improves exercise tolerance in patients with thoracic restriction. Tuggey and Elliot 26 have demonstrated that a high-pressure support (+19 cm H 2 O in our study) is needed to achieve blood gases normalization whereas more limited support allows rapid unloading of respiratory muscles.
The reduction in oxygen pulse at the end of exercise observed in the most severe patients in the present study suggests that reduced ejection fraction may contribute to exercise limitation. In a model of thoracic restriction in healthy volunteers, Miller et al. 25 showed a fall in cardiac output during moderate intensity exercise. Also, in primary pulmonary hypertension, patients had low oxygen pulse value during exercise corresponding to a limited increase in stroke volume. 27, 28 In our study, NIV could reduce heart rate directly by preventing oxygen desaturation and indirectly by limiting hypoxic vasoconstriction and reducing pulmonary hypertension. This could lead to a higher stroke volume and allow reduction in heart rate at the same cardiac output for a given level of exercise. 29 Moreover, a higher Vt during NIV being associated with a lung volume-dependant decrease in sympathetic tone may have had additional effects in decreasing sympathetic activation. 30, 31 Considering that oxygen desaturation is one of the main factors limiting exercise in restrictive patients, one can argue that oxygen supplementation during exercise could have led to similar results than NIV application. However, whereas oxygen therapy could relieve dyspnea, its use did not improve the 6 min walking distance in patients with kyphoscoliosis. 6 In patients with tuberculosis sequellae, Tsuboï et al. 17 compared oxygen therapy versus VNI+O 2 and showed a significant increase in endurance time (from 227764 to 4657201 s). These data suggest that VNI per se has a specific and synergistic role with oxygen in improving exercise capacity in CRF.
Clinical implications and conclusion
In severely restrictive patients, NIV during exercise increases exercise duration, improves exercise tolerance and alveolar ventilation. Both the presence of low vital capacity at rest (one liter or less) and inefficient ventilation during exercise (high V D /V T ratio) could discriminate responders and non-responders to NIV during exercise.
The magnitude of changes in exercise endurance is much more pronounced than previously reported in COPD. Thus, with NIV, restrictive patients could be able to exercise longer and therefore get a greater training effect during a pulmonary rehabilitation program. This however remains to be demonstrated.
